Intensity Therapeutics, Inc. (INTS) Q2 2023 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and welcome to the Intensity Therapeutics second quarter 2023 conference call and webcast. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing star then zero on your telephone keypad. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star then two. Please note this event is being recorded. I would now like to turn the conference call over to our host, Michael Miller of RX Communications. Please go ahead. Thank you, operator. Good morning, and thank you for joining the Intensity Therapeutics conference call to review the financial and operating results for the second quarter ended June 30th, 2023. I'm joined today by Lewis H. Bender, Founder and Chief Executive Officer, and John Wesolowski, Chief Financial Officer. As a reminder, this conference call contains forward-looking statements within the meaning of the federal securities laws. The company's actual results may differ materially from those projected in the forward-looking statements. Additional information concerning factors that might cause actual results to differ materially from those in the forward-looking statements is contained in the company's periodic reports filed with the Securities and Exchange Commission. The information presented today is time sensitive and is accurate only as the date of this call, August 14th, 2023. If any portion of this call is being rebroadcast, retransmitted, or redistributed at a later date, Intensity Therapeutics will not be reviewing or updating this material. I would now like to turn the call over to Mr. Bender. Please go ahead, Lou. Thank you, Mike. Go...